Brief: Exact Therapeutics H1 Oper Loss Narrows To NOK 26.3 Mln
22/09/2022 07:10
Sept 22 (Reuters) - Exact Therapeutics AS EXTX.OL :
* H1 OPERATING LOSS NOK 26.3 MILLION VERSUS LOSS NOK 36.4
MILLION
YEAR AGO
Source text for Eikon: ID:nObiS1mjCa
Further company coverage: EXTX.OL
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Exact Therapeutics AS
See all newsBrief: EXACT Therapeutics AS Gets Positive Safety Review For 60 Μl/Kg Dose In Phase 2 ENACT Trial
Brief: Exact Therapeutics Introduces New Long-Term Incentive Program
Brief: Exact Therapeutics H1 Operating Loss Widens To NOK 45.9 Million
Brief: Exact Therapeutics Announces Grant Of Core Patent In U.S.
Brief: Exact Therapeutics Announces Final Positive Data From Phase 1 Trial